Test Code SCL70 SCL-70 Ab
Additional Codes
Meditech Order: SCL-70AB
Panel Order:ENAE
Intended Use
EliA Scl-70S is intended for the in vitro semi-quantitative measurement of IgG antibodies
directed to Scl-70 in human serum and plasma (Li-heparin, EDTA) as an aid in the clinical
diagnosis of scleroderma (diffuse form) in conjunction with other laboratory and clinical
findings. EliA Scl-70S uses the EliA IgG method on the instrument Phadia 250
Alias
Scleroderma 70 Ab
SCL70
Performing Lab
Boone Health Laboratory
Collection Method
Venous Collection
Container
Gold Serum Tube
Instructions/Special Handling
None
Preferred Specimen
Gold SST Serum Tube
Red Serum
Acceptable Specimes
- Plasma
- Lithium Heparin
- EDTA
Units
| EliA U/mL |
Reference Ranges
| <7 | Negative |
| >10 | Positive |
| 7-10 | Equivoval (recommend retesting after 8-12 weeks) |
| >240 | >240 EliA U/mL |
Critical Values
N/A
Reasons for Rejection
| Hemolysis | >496 |
| Icterus | >19.2mg/dL |
| Lipemia | >1000 |
| Other | Contaminated specimens, Rheumatoid Factor IgM >500,QNS, Improperly labeled, Improper specimen type |
Specimen Stability
| Ambient (15-25°C) | 8 hours |
| Refrigerated (2-8°C) | 14 days |
| Frozen (-20°C) | 12months (only one freeze thaw cycle) |
Performance Information
| Days/Times Performed | Monday, Wednesday and Friday |
| Expected Turn around Time | 1-3 days |
| Methodology/Method Description | EliA IgG |
CPT Code(s)
86235